在心脏手术期间使用高灵敏度的Troponin T来定义外科手术期间的心肌损伤
Vikram Sharma1, Huili Zheng2, Luciano Candilio3
1Department of Cardiovascular Medicine, University of Iowa, Iowa City, IA 52242, USA.
Journal of clinical medicine
|July 14, 2023
概括
心脏手术后高灵敏度托罗T (hs-TnT) 的升高表明死亡风险较高. 一个24小时的术后hs-TnT水平是指标上限的50倍,最能预测1年生存率.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 生物标志物 生物标志物
背景情况:
- 在心脏外科手术后使用高灵敏度热素 (hs-Tn) 切断界限来定义术前心肌损伤 (PMI) 仍然具有挑战性.
- 准确识别PMI对于患者的预后至关重要.
研究的目的:
- 评估心脏外科手术患者手术前高灵敏度托邦素T (hs-TnT) 升高与1年全因死亡率之间的关联.
- 为了确定可靠的hs-TnT预后显著的PMI的截止值.
主要方法:
- 一项涉及1206名患者的ERICCA试验的后期分析.
- 评估基线和各种手术后hs-TnT值 (测量在6,12,24,48,72小时) 的1年全因死亡率.
- 对基线hs-TnT和EuroSCORE进行统计调整.
主要成果:
- 基线hs-TnT升高>1x第99百分点URL与1年死亡率增加有关 (aHR为1.90).
- 在正常基线hs-TnT的患者中,观察到显著的死亡风险,手术后24小时后的URL升高≥50 × URL.
- 24小时后hs-TnT升高≥50×URL显示出最佳的灵敏度 (73%) 和特异性 (75%) 预测死亡率.
结论:
- 基线和术后hs-TnT升高都是心脏手术后1年全因死亡率的独立预测指标.
- 在手术后24小时,hs-TnT升高≥50×URL被认为是定义预后显著PMI的最佳值.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
202
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
202
Acute Coronary Syndrome I: Introduction
31
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
31
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Cardiomyopathy VII: Pre and Post Operative Nursing Management
16
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Cardiac Catheterization I: Pre-Procedure Overview
69
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
69


